NDC 70518-3780-01 - HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3780
- Requested NDC
- 70518-3780-01
- Package NDCs from labels
- 70518-3780-0, 70518-3780-1, 70518-3780-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2025-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS, USP Rx only | REMEDYREPACK INC. | 2025-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3780-0 | HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 4 | |
| 70518-3780-1 | HYDROCHLOROTHIAZIDE | 30 in 1 BLISTER PACK | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3780 | HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 4 | Current NDC, 2 package rows | 20250508_1570f1ad-8372-477f-89c3-8c9ce01e27d1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 82ad0fdf-5d47-4c2d-883b-f28b2d3fb6b0 | 2025-04-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | fea5a353-9b13-9b87-e053-6394a90a627d | 2025-04-25 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | NorthStar RxLLC | 364af4fe-cde8-466f-b56f-d93d532b56f5 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Strides Pharma Science Limited | 9b76e441-e6a5-4036-8276-b7788ade5c44 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Zestoretic | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Almatica Pharma Inc. | 0d3a966f-f937-05a8-a90f-5aa52ebbd613 | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | e05e3314-5520-4bbd-b7f0-623afd9ba569 | 2025-03-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 852c6f3f-d3f5-0d99-e053-2991aa0aa9c3 | 2025-02-21 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| LISINOPRIL and HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | GSMS, Incorporated | d02a0d38-676a-4e0f-9aa2-0a6c56cd7361 | 2025-02-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | e0f63126-6890-48bf-9c25-444dc5974ecd | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 5e35e3b9-7d79-b32a-e053-2991aa0ae9c0 | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 4c1a2fb9-133d-4bd5-a336-e47d54f22c97 | 2025-02-01 | Warnings, Adverse reactions | 310798 197770 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8b36fa56-4274-4fc6-bdba-ca7a399b2b21 | 2025-01-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Redpharm drug | fa1c0b92-4360-bcfd-e053-6394a90a955a | 2025-01-23 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Direct_Rx | 05156717-fe1b-22f1-e063-6394a90a3d10 | 2025-01-22 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Ajanta Pharma USA Inc. | 8b78d7ad-22a8-4a9f-afb5-d18f0a4e6d36 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d8284747-07b6-9775-e053-2a95a90ad52d | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d88ad738-a915-7679-e053-2a95a90a58c7 | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 93f6a018-8b3d-4f40-be25-902daec19aea | 2025-01-21 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | DIRECT RX | cbe5e01e-67ca-f8a2-e053-2995a90a0d15 | 2025-01-20 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.